We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,835.00
Bid: 2,836.00
Ask: 2,837.00
Change: -11.00 (-0.39%)
Spread: 1.00 (0.035%)
Open: 2,822.00
High: 2,841.00
Low: 2,789.00
Prev. Close: 2,846.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Performance update

28 Jan 2016 07:00

RNS Number : 2299N
3i Group PLC
28 January 2016
 

 

28 January 2016

 

 

3i Group plcFY2016 Q3 performance update 

 

3i Group plc ("the Group" or "3i") today issues its performance update relating to the third quarter from 1 October 2015 to 31 December 2015 ("the quarter") of FY2016.

 

 

Another solid quarter with some important transactions and strong earnings growth

 

§ NAV per share of 413 pence and total return of 7.4%

§ Realised £403 million in the 9 months to 31 December 2015, excluding the c.£188 million due from the sale of Element Materials Technology

§ Invested £364 million in Private Equity in the 9 months to 31 December 2015 with three new investments

§ Launched two new CLOs in Debt Management in the quarter, one in Europe and one in the US

§ The portfolio companies in Private Equity continue to perform well with a good increase in unrealised value supported by value weighted earnings growth, including acquisitions, of 18%

 

Simon Borrows, Chief Executive, commented:

 

"This was another steady quarter for 3i. We delivered a solid result, supported by good levels of investment and divestment activity, despite the challenging market backdrop. Our portfolio companies continue to perform well with strong unrealised value growth from a number of our key investments such as Action, 3i Infrastructure plc, Scandlines and GIF.

 

Investment activity was strong in the quarter, with the highly profitable sale of Element Materials Technology at 4.5x euro cost and the purchase of Audley Travel, a business with excellent growth potential. We have a good level of planned realisations and an interesting pipeline of potential new investments, but we remain disciplined on price given the broader macroeconomic and market uncertainties.

 

With earnings growth, including acquisitions, of 18% and average gearing under 3x EBITDA in Private Equity, we expect our investment portfolio to continue to demonstrate its resilience as we complete the important final quarter of our financial year."

 

 

 

Private Equity

 

Investments

The team had a busy end to the 2015 calendar year. We completed a £159 million investment in Audley Travel, a market leader in tailor-made luxury travel based in the UK and with a growing presence in the United States. On completion of the transaction, 3i also underwrote an £87 million loan pending the refinancing of Audley Travel's debt facilities. This amount was repaid in full on 27 January 2016.

 

Total

Proprietary Capital

investment

investment

Audley Travel1

£159m

£156m

H1 2016 investment

£247m

£208m

Total cash investment as at 31 December 20151

£406m

£364m

 

1

Cash invested in Private Equity excludes the £87 million (£85 million 3i Proprietary Capital) loan underwritten on behalf of Audley Travel which was repaid on 27 January 2016.

 

Realisations

We received total cash proceeds in the quarter of £43 million. This included proceeds of £17 million from the refinancing of Geka, as well as proceeds of £20 million from a partial sale of our quoted holding in Refresco Gerber and the full sale of Consultim.

 

On 17 December 2015, we announced the sale of our investment in Element Materials Technology ("Element"), with estimated proceeds of £188 million, representing a 12% uplift against the value at 30 September 2015 and a 30% uplift against the value at 31 March 2015. Inclusive of the proceeds from Element's refinancing completed in August 2014,the transaction will generate a 4.5x euro money multiple (3.9x in sterling) and is expectedto complete before 31 March 2016. Element was valued on an imminent sale basis at31 December 2015.

 

3i realisation proceeds

Full realisations

Consultim

£10m

Vijai

£4m

Other

£1m

Partial realisations

Refresco Gerber

£10m

Refinancings

Geka

£17m

Deferred consideration

Other

£1m

Total Q3 2016 cash proceeds

£43m

H1 2016 cash proceeds

£307m

Total cash proceeds as at 31 December 2015

£350m

Element

£188m

Total Private Equity realisation proceeds including Element

£538m

 

Portfolio performance

The underlying Private Equity portfolio performed well in the quarter despite the challenging macroeconomic and market conditions. The portfolio has limited direct exposure to regions or sectors that have shown weakness over recent months, such as emerging markets or oil and gas or commodities. Value weighted earnings growth, including the effect of portfolio acquisitions, over the last twelve months was 18% (September 2015: 19%) and 12% excluding Action (September 2015: 14%).

 

Action, our largest investment, maintained its strong like for like revenue and EBITDA growth, excellent cash flow generation and good progress on store openings, resulting in strong unrealised value growth for this asset. Action's momentum in trading and store openings has continued through its final quarter. Together with the good levels of unrealised value generated from assets such as Scandlines and GIF, this more than offset the continued negative effect of weak macroeconomic and market conditions on the valuation of assets such as AES, Dynatect, Etanco and JMJ.

 

The value weighted average EBITDA multiple used to value the Private Equity portfolio decreased by 1% to 11.3x before liquidity discount and 10.7x after liquidity discount in the quarter. Excluding Action, the multiple before liquidity discount decreased by 3% to 9.8x (post discount: 9.2x).

 

Top 10 investments by value at 31 December 2015

 

Valuation1

Valuation1

Valuation

Valuation

Sep-15

Dec-15

basis

currency

£m

£m

Activity in the quarter

Action

Earnings

Euro

712

797

3i Infrastructure plc

Quoted

GBP

450

463

£10m interim 2016 dividend accrued within income

Scandlines

DCF

Euro

257

271

Element

Imminent sale

USD

168

182

Sale signed in December 2015 and completion expected by March 2016

Amor / Christ

Earnings

Euro

174

174

Audley Travel

Price of recent investment

GBP

-

156

The £85m loan, repaid on 27 January 2016, is accounted for as a current debtor

Weener Plastic

Earnings

Euro

149

151

Basic-Fit

Earnings

Euro

119

123

GIF

Earnings

Euro

106

120

Q Holding

Earnings

USD

117

117

 

1

Balance sheet values are stated after foreign exchange translation.

 

The top 10 investments in this table comprise 60% (30 September 2015: 57%) of the total Proprietary Capital portfolio by value. This table does not include one investment that has been excluded for commercial reasons.

 

 

Infrastructure

 

The European portfolio continued to perform well, and during the quarter the 3i Infrastructure plc ("3iN") share price increased by 3% to 172 pence at 31 December 2015, following a strong set of half-year results. This generated a value gain of £12 million for 3i during the quarter in addition to dividend income of £10 million. 3i received a £51 million special dividend in the first half which was included in realisation proceeds.

 

 

Debt Management

 

The Debt Management team closed Harvest XIV, a new European CLO, for €414 million and Jamestown VIII, a new US CLO, for US$504 million, generating new assets under management of £636 million. 3i invested a total of £33 million into these CLOs.

 

 

Total return and NAV position

 

Value growth from the Private Equity portfolio and 3iN resulted in an increase in diluted NAV per share to 413 pence (30 September 2015: 401 pence). The foreign exchange impact was nil pence in the quarter despite significant intra-period volatility. Both the euro and US dollar have continued to strengthen since the quarter end. As at 31 December 2015, a 1% movement in the euro and US dollar would result in a total return movement of £21 million and £5 million respectively.

 

 

Balance sheet and dividend

 

The Group's balance sheet remains strong. Gross debt and liquidity at 31 December 2015 remained stable at £820 million and £950 million respectively. Net debt increased to £220 million, principally due to the investment in Audley Travel. Notable cash movements post quarter end include the 6p interim dividend paid to shareholders on 6 January 2016 and the £85 million refinancing of Audley Travel that completed on 27 January 2016. The sale of our investment in Element is expected to complete before the end of our 2016 financial year.

 

- Ends -

 

 

For further information, please contact:

 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

 

Kathryn van der KroftCommunications DirectorTel: 020 7975 3021

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

All statements in this performance update relate to the three month period ended 31 December 2015 unless otherwise stated. The financial information is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Net asset value ("NAV") and total return are the same on the Investment basis and on an IFRS basis. Details of the differences between 3i's consolidated financial statements prepared on an IFRS basis and under the Investment basis are provided in the 2015 Annual report and accounts. There have been no material changes to the financial position of 3i from the end of this quarter to the date of this announcement.

 

 

Notes

 

1. Uplift on opening value represents the cash proceeds received in the year to date over the March 2015 opening value realised.

 

2. Money multiple over cost represents the cash proceeds (including income) over cash invested.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEMFAWFMSEFF
Date   Source Headline
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.